Skip to main content
. 2018 Sep 28;37(24):e99559. doi: 10.15252/embj.201899559

Figure 3. CDKL5‐dependent phosphorylation of MAP1S and CEP131 in cells.

Figure 3

  1. CDKL5 phosphorylates MAP1S at Ser900 in human cells. HEK293 cells were co‐transfected with CDKL5 (wild type “WT” or kinase‐dead K42R mutant) and/or FLAG‐MAP1S (wild type “WT” or a S900A mutant “SA”). Anti‐FLAG precipitates were subjected to Western blotting with the antibodies indicated. “Hi” higher exposure; “lo” lower exposure. The input extracts were also subjected to immunoblotting (lower panels). Three independent experiments were done, and one representative experiment is shown.
  2. CDKL5 phosphorylates CEP131 at Ser35 in human cells. HEK293 cells were co‐transfected with CDKL5 (wild type “WT” or kinase‐dead K42R mutant) and/or FLAG‐CEP131 (wild type WT or a S35A mutant). Anti‐FLAG precipitates were subjected to Western blotting with the antibodies indicated. “Hi” higher exposure; “lo” lower exposure. The input extracts were also subjected to immunoblotting (lower panels). Three independent experiments were done, and one representative experiment is shown.

Source data are available online for this figure.